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ABSTRACT
Approximately 15% of all ischemic strokes (IS) occur in young adults and adolescents. To date, only
limited prior public health and research efforts have specifically addressed stroke in the young. Early
diagnosis remains challenging because of the lack of awareness and the relative infrequency of
stroke compared with stroke mimics. Moreover, the causes of IS in the young are heterogeneous
and can be relatively uncommon, resulting in uncertainties about diagnostic evaluation and cause-
specific management. Emerging data have raised public health concerns about the increasing prev-
alence of traditional vascular risk factors in young individuals, and their potential role in increasing
the risk of IS, stroke recurrence, and poststroke mortality. These issues make it important to formu-
late and enact strategies to increase both awareness and access to resources for young stroke
patients, their caregivers and families, and health care professionals. The American Academy of
Neurology recently convened an expert panel to develop a consensus document concerning the rec-
ognition, evaluation, and management of IS in young adults and adolescents. The report of the con-
sensus panel is presented herein. Neurology 2013;81:1089–1097
GLOSSARY
CI 5 confidence interval; ICH 5 intracerebral hemorrhage; IS 5 ischemic stroke; PFO 5 patent foramen ovale.
Approximately 15% of all ischemic strokes (IS) occur in young adults and adolescents.1–8
Compared with stroke in older adults, stroke in the young has a disproportionately large eco-
nomic impact by leaving victims disabled before their most productive years. To date, only
limited prior public health and research efforts have specifically addressed stroke in the young.
Early diagnosis remains challenging because of the lack of awareness and the relative infrequency
of stroke compared with stroke mimics. Moreover, the causes of IS in the young are heteroge-
neous and relatively uncommon,3,8,9 resulting in uncertainties about diagnostic evaluation and
cause-specific management. Emerging data have raised public health concerns about the increas-
ing prevalence of traditional vascular risk factors in young individuals, and their potential role in
increasing the risk of IS, stroke recurrence, and poststroke mortality.5–8,10,11 These issues make it
important to formulate and enact strategies to increase both awareness and access to resources for
young stroke patients, their caregivers, and health care professionals. The American Academy of
Neurology convened an expert panel to develop a consensus document concerning IS in young
adults and adolescents. Given the relative lack of high-level scientific evidence concerning stroke
in young individuals, an evidence-based management guideline was considered unfeasible. The
report of the consensus panel is presented herein.
EPIDEMIOLOGY As young adults approach middle age, stroke prevalence increases5,7 (table 1). Based on self-
report, 532,00012 to 852,00013 persons aged 18 to 44 years in the United States have had a stroke. For
comparison, among adults aged 17 to 44 years, the self-reported prevalence of stroke is more than twice that of
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multiple sclerosis.14 Of all strokes among persons 15
to 44 years of age, approximately 50% are IS, 20% are
intracerebral hemorrhage (ICH), and 30% are suba-
rachnoid hemorrhage.4 Incidence rates for IS in this
age range are approximately 10 per 100,000 person-
years for US populations of predominantly European
ancestry,15,16 with similar rates for men and women.
Compared with persons of European ancestry, Afri-
can Americans have incidence rates 2-fold higher for
IS.15 It should be acknowledged that the available
epidemiologic data are mostly based on national sur-
veys and population-based studies, the upper age cut-
off has varied from 44 years to 55 years, and stroke
remains underrecognized in this population. These
issues limit our understanding of the causes of stroke
in the young and its true incidence and prevalence.
There are conflicting data on trends in incidence
rates over time. Data from Sweden for first discharge
for stroke among persons aged 20 to 44 years show
no trend over time.16 In contrast, analyses of all dis-
charges for stroke among persons aged 15 to 44 years
from the USNationwide Inpatient Sample from 1995–
1996 through 2008–2008 show a 23% to 53%
increase for IS, depending on the age-sex group.5
There was a concurrent trend for an increasing prev-
alence of stroke risk factors in this age range, specif-
ically hypertension, diabetes mellitus, obesity, lipid
disorders, congenital heart disease, and smoking.
Similar increasing trends were recently reported in
a population-based study.7 Other studies1,8,11 have
shown that young stroke patients have a high inci-
dence of modifiable vascular risk factors, which con-
tribute a nearly 12% risk of recurrent cardiovascular
events and increased 5-year mortality.6,10 A prospec-
tive cohort study showed that the observed 20-year
mortality rates (24.8% for TIAs and 26.8% for IS)
were significantly higher than expected mortality
rates.17 These data emphasize the importance of im-
plementing primary and secondary vascular preven-
tive strategies in young individuals.
RECOGNITION AND DIFFERENTIAL DIAGNOSIS
Younger patients are less likely to utilize 911 and pre-
hospital systems for stroke-like symptoms because
they do not appreciate they are at risk of stroke. Even
after arrival to the emergency department, the diagno-
sis is often delayed or missed18 because stroke is still
considered a disease of the elderly, and because young
individuals may not have vascular risk factors to raise
suspicion for stroke.
Few studies have addressed the reasons for under-
diagnosis of stroke in the young. In a single-center
analysis of 57 IS patients aged 16 to 50 years, 8 were
initially misdiagnosed, including 7 who were initially
discharged.18 Predictors of a missed diagnosis were
age younger than 35 years and posterior-circulation
stroke. Early (,48-hour) MRI may reduce the rate
of misdiagnosis. There is more literature regarding
stroke overdiagnosis (false-positives), an important
concern given the potential risks of thrombolytic
complications in stroke mimics. Approximately
20% to 50% of adults and children with acute
stroke-like symptoms will prove to have an alternative
diagnosis.19–21 The most frequent mimics of IS in
young adults and adolescents are seizures, acute ves-
tibular syndrome, migraine, infections, brain tumors,
toxic-metabolic encephalopathy (particularly hypo-
glycemia), hypertensive encephalopathy, gastroenter-
itis, and conversion disorder. Less frequent sources of
misdiagnosis are cardiac events, herpes-simplex virus
encephalitis, demyelinating disease, and myasthenia
gravis. Among patients treated with IV thrombolysis,
the proportion of mimics is lower, between 3% and
13%.22 Reassuringly, among young patients with
stroke (including mimics) treated with IV thrombol-
ysis, there does not seem to be an increased risk of
symptomatic ICH.8,22,23
The symptoms of IS in young adults and adoles-
cents are often similar to those in older patients.
The diagnosis is straightforward when presented with
typical stroke symptoms such as an acute hemiparesis.
However, the diagnosis becomes challenging with
atypical symptoms (table 2).24 A few salient points
are worth highlighting. Right-hemispheric strokes
are often misdiagnosed initially because language is
preserved. Nonlocalizing syndromes, including neu-
ropsychiatric symptoms, acute confusional states, and
diminished level of alertness, may sometimes be the
presenting features. Even small infarcts in the mid-
brain and thalamus may cause diminished levels of
alertness. While strokes usually cause negative symp-
toms such as weakness, positive symptoms can
develop, including unilateral limb-shaking, hemibal-
lismus, or chorea. In patients presenting with dizzi-
ness, it is particularly difficult to distinguish stroke
from vestibular neuronitis or Ménière disease. There
is evidence that the presence of a negative head-
impulse test, skew deviation, or direction-changing
nystagmus in eccentric gaze has a sensitivity of
100% and specificity of 96% for stroke.25 Patients
Table 1 Prevalence of stroke by age and sex,
NHANES 1998–2002
Age, y Men, % Women, %
20–34 0.4 0.3
35–44 1.1 0.8
45–54 1.2 2.1
Abbreviation: NHANES 5 National Health and Nutrition
Examination Survey.
National Heart, Lung, and Blood Institute data.
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should not be dismissed unless they can walk without
imbalance. Patients with severe nausea and vomiting
due to missed cerebellar infarction may later experi-
ence fatal brainstem compression due to swelling,
a condition ironically labeled “fatal gastroenteritis.”
Patients presenting with isolated symptoms (e.g., cra-
nial neuropathies, visual symptoms, pure sensory loss,
monoparesis) may also be misdiagnosed because these
are relatively uncommon.
Several studies have shown an increased risk of
stroke in patients with migraine with aura, especially
women younger than 45 years, cigarette smokers, and
those using hormonal contraception.26 In migraineurs
who present with prolonged focal neurologic symp-
toms, particularly visual or language disturbance, it
can be challenging to distinguish migraine from
stroke. Migraine-induced stroke is extremely rare,
should always be the diagnosis of exclusion, and the
criteria of the International Headache Society’s Inter-
national Classification of Headache Disorders, 2nd edi-
tion27 should be fulfilled in order to make this
diagnosis. The absence of a history of migraine with
aura, or a change in the quality of headache, should
make one question the diagnosis of migraine. More-
over, sensory changes in migraine usually have a
migrating quality, moving over 20 to 30 minutes
across parts of the body, whereas stroke-related sen-
sory changes usually occur abruptly. Adolescents and
children usually have a headache or a seizure at the
time of stroke onset and the presence of either can
falsely reassure providers that a child with new focal
deficits has a complicated migraine or postictal Todd
paralysis.
STROKE ETIOLOGY The causes of IS in young adults
and adolescents are diverse (table 3)28 and vary by age
and geographic region.1–5,8,15,29 Contemporary stroke
etiologic classification schemes have attempted to grade
causality according to the level of evidence and the pres-
ence of multiple potential causes.8,30,31 Because the inci-
dence of IS strongly correlates with increasing age, the
causes listed in table 2 are, in the aggregate, considered
uncommon. Arteriopathies, including mainly nonather-
osclerotic arteriopathies such as dissection as well as
premature atherosclerosis, are collectively the most com-
mon cause of IS in young individuals.29,32 Relative to
adults older than 55 years, young individuals infre-
quently develop stroke from atherosclerosis; however,
the older end of the young-adult age range still has a
higher incidence of atherosclerotic stroke due to the
concurrence of multiple modifiable risk factors such as
hypertension, cigarette smoking, and hyperlipidemia.
CLUES FORSPECIFIC ETIOLOGIES Certain histor-
ical features, symptoms, and signs may serve as clues
toward specific stroke etiologies.9 Recent minor
trauma or sudden neck movements, including chiro-
practic neck manipulation or vigorous exercise, are
associated with arterial dissection.33 Patients with cer-
vical artery dissection will frequently complain of
headache or neck pain. A painful Horner syndrome,
or coexisting cranial neuropathies, should always raise
suspicious for dissection; all cranial nerves except the
olfactory nerve may be affected by dissection.
Clinical clues to the presence of an underlying arte-
riopathy include headache (particularly recurrent
“thunderclap” headache), recurring stereotyped TIAs,
psychiatric disturbances, skin rash, exposure to vaso-
constrictive agents, pregnancy, hormonal contraceptive
Table 2 Atypical stroke presentations
Nonlocalizing symptoms
Neuropsychiatric symptoms
Acute confusional state/delirium
Depressed level of consciousness
Abnormal movements
Chorea
Hemiballismus
Dystonia
Unilateral asterixis
Hemifacial spasm
Alien hand syndrome/deafferentation
Limb-shaking TIAs
Seizures secondary to stroke
Cranial neuropathies
Acute vestibular syndrome
Acute hearing loss
Ischemic optic neuropathy
Horner syndrome
Third nerve palsy
Seventh nerve palsy
Other cranial neuropathies
Isolated symptoms
Isolated dysarthria
Isolated dysphagia/stridor
Isolated facial paresis
Monoparesis of arm or leg or a part of limb or distal
extremity
Isolated sensory symptoms
Isolated visual loss
Isolated headache
Headache
Adapted from The Lancet Neurology, 10, Edlow JA, Selim
MH. Atypical presentations of acute cerebrovascular syn-
dromes, 550–560, Copyright 2011, with permission from
Elsevier.
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use, head trauma, and HIV infection.9,32 Transient
cerebral arteriopathy is the most common cause of
stroke in children, but typically has no clinical clues.34
Genetic disorders are suggested by abnormal eye and
skin examination findings such as retinal arteriolar
irregularities, ectopia lentis (Marfan syndrome), iris
hamartomas and optic nerve tumors (neurofibromato-
sis), cataracts, corneal opacities, angiokeratomas (Fabry
disease), hyperelastic skin (Ehlers-Danlos type IV), and
neurofibromas or café-au-lait spots (neurofibromato-
sis). On brain imaging, it is important to consider
stroke lesion topography; e.g., a unilateral “string-of-
pearls” appearance may indicate middle- or internal-
cerebral artery stenosis.
A history of recent prolonged immobility, such as
after recent surgery, should raise suspicion for para-
doxical embolism through a patent foramen ovale
(PFO). Fevers, back pain, and joint pain should raise
concern for endocarditis. Clues for a hypercoagulable
state include a history of deep venous thrombosis or
multiple miscarriages. Skin examination may reveal
underlying coagulation problems, vasculitis, endocar-
ditis, or stigmata of IV drug abuse.
LABORATORY TESTS Given the broad spectrum of
etiologies (table 3), the fear of litigation from missing
ominous or rare causes, and the absence of evidence-
based diagnostic algorithms, young stroke patients are
invariably subjected to a wide array of diagnostic tests,
often ordered simultaneously at the time of presenta-
tion. This includes the usual test panel performed for
any stroke patient, and specialized tests9 for causes
relatively more frequent in young patients (table 4).
The clinical clues outlined above should be consid-
ered to tailor the diagnostic work-up, and an orga-
nized, stepwise evaluation should follow.
The yield of several diagnostic tests was investi-
gated in a small retrospective study (figure).8 The
yield was relatively low for Holter monitoring (1%)
and toxicology screening (5%), and relatively high for
cardiac ultrasound (51%) and cerebral angiography
(64%). Others have shown a similar high yield for
cerebral angiography.1,2 Because younger patients are
at higher risk of developing leukemia and brain tu-
mors from CT scans, exposure to radiation should be
limited when possible.35 The clinical significance and
treatment implications of findings such as a positive
hypercoagulable panel test result, or a PFO on cardiac
ultrasound, remain controversial.36–39 Nevertheless,
in view of the variable yield and high cost of special-
ized tests, it seems justified to routinely perform high-
yield tests such as cardiac ultrasound and vascular
imaging in young stroke patients. More research is
warranted to determine the cost-effectiveness of diag-
nostic tests and design appropriate strategies to eval-
uate stroke in the young.
Table 3 Selected causes and risk factors for ischemic stroke in young adults and
adolescents
A. Frequency of stroke etiologya
Large-vessel atherosclerosis (2%–11%)
Small-vessel disease (7%–14%)
Cardiac embolism (20%–47%)
Other determined etiology (20%–34%)
Multiple etiologies (2%–3%)
B. Arterial
1. Cerebral artery dissection
2. Reversible cerebral vasoconstriction syndromes
3. Moyamoya disease
4. Sickle cell disease
5. Transient cerebral arteriopathy of childhood
6. Premature atherosclerosis, lipohyalinosis
7. Radiation-induced arteriopathy
8. Migraine-induced stroke
9. Illicit drug abuse (e.g., cocaine, amphetamines, ecstasy)
10. Infectious arteriopathy (e.g., post-varicella; tuberculous, fungal, or bacterial meningitis;
syphilis, HIV)
11. Inflammatory arteriopathy (e.g., Takayasu arteritis, giant cell arteritis, primary angiitis of the
CNS, polyarteritis nodosa, Behçet disease, Churg-Strauss syndrome, Kohlmeier-Degos
disease)
12. Genetic or inherited arteriopathy (e.g., Fabry disease, fibromuscular dysplasia,
dolichoectasia, Susac syndrome, cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy, TREX1 mutation disorders, mitochondrial
encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS),
hyperhomocysteinemia, neurofibromatosis type 1)
C. Cardiac
1. Patent foramen ovale
2. Congenital heart disease
3. Infectious and nonbacterial thrombotic endocarditis
4. Rheumatic valvular heart disease
5. Post-cardiac surgery or catheter intervention
6. Arrhythmia (e.g., atrial fibrillation, sick sinus syndrome)
7. Cardiac tumors (e.g., atrial myxoma, papillary fibroelastoma)
8. Recent myocardial infarction
9. Dilative cardiomyopathy
D. Hematologic
1. Heparin-induced thrombocytopenia
2. Hypercoagulable state due to deficiencies of protein S, protein C, or antithrombin; factor V
Leiden mutation, prothrombin gene G20210A mutation
3. Acquired hypercoagulable state (e.g., cancer, pregnancy, hormonal contraceptive use,
exposure to hormonal treatments such as anabolic steroids and erythropoietin, nephrotic
syndrome, antiphospholipid antibody syndrome)
4. Primary hematologic disorders (e.g., polycythemia vera, essential thrombocythemia,
paroxysmal nocturnal hemoglobinuria, thrombotic thrombocytopenic purpura, leukemia,
lymphoma, multiple myeloma)
aClassified according to the Trial of Org 10172 in Acute Stroke Treatment schema.
From New England Journal of Medicine, Yager PH, Singhal AB, Nogueira RG, Case records of
the Massachusetts General Hospital. Case 31-2012. An 18-year-old man with blurred
vision, dysarthria, and ataxia, 367, 1450–1460. Copyright © 2012 Massachusetts Medical
Society. Reprinted with permission.
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ACUTE MANAGEMENT Emergent treatment of
younger stroke patients is similar to older patients.40
Recommendations for physiologic management, e.g.,
blood pressure, temperature, glucose, and oxygena-
tion, as well as thrombolysis, are the same as for older
stroke patients. Younger patients benefit from access
to stroke expertise and ideally should be admitted to
comprehensive stroke centers with neurocritical care
units.41 Those with large strokes, especially malignant
middle-cerebral artery infarction, require aggressive
neurocritical care monitoring, intracranial pressure
management, and early assessment for decompressive
hemicraniectomy, which not only lowers mortality
but also improves long-term neurologic and func-
tional outcomes.42 Several studies have shown that
reperfusion strategies are efficacious and appear to
be safe in young adults.8,23,43–45 For example, in one
study, young patients (18–50 years) had significantly
better functional outcome and lower rates of symp-
tomatic brain hemorrhage and 3-month mortality
compared with older patients (51–80 years).43 At pre-
sent, thrombolysis is approved only for those aged 18
years and older; the ongoing NIH-funded Thrombol-
ysis in Pediatric Stroke trial will provide safety and
dosing data for thrombolysis in children and
adolescents.46
STROKE PREVENTION As stated, young stroke sur-
vivors have substantial rates of modifiable vascular
risk factors, which contribute significantly to stroke
recurrence and mortality. Young adults with or with-
out stroke warrant multimodal efforts to adopt
healthy lifestyles, treat vascular risk factors aggres-
sively, and abstain from recreational drug use includ-
ing marijuana.47,48 In one cohort, a disappointingly
low 22% of young adults with IS gave up smoking.49
Although young adults are underrepresented in
randomized controlled trials of secondary stroke pre-
vention, we can extrapolate from the results of some
of these trials. The Perindopril Protection Against
Recurrent Stroke Study trial included younger indi-
viduals and found that the specific combination of
angiotensin-converting enzyme inhibitor and thiazide
diuretic reduced recurrent stroke in stroke survivors
with or without hypertension defined as blood pres-
sure .160/90 mm Hg. The benefit was greater in
stroke survivors younger than 65 years compared with
those 65 years and older50 and observed in those with
isolated diastolic hypertension or systolic-diastolic
hypertension (hypertension types more common in
younger adults).51 The Stroke Prevention by Aggres-
sive Reduction in Cholesterol Levels trial of adults
aged 18 years and older with recent IS or ICH showed
that 80 mg of atorvastatin, a high-potency statin,
reduced recurrent stroke compared with placebo.52
Although statin therapy was associated with fewer
recurrent vascular events in young patients with cryp-
togenic stroke,53 it remains controversial whether all
young stroke patients with predominantly nonather-
osclerotic stroke etiologies should receive statins.
A detailed review of the prevention of stroke from
specific etiologies is outside the scope of this article.
Published guidelines of stroke prevention in infants
and children address many of these entities.54 How-
ever, a few common conditions will be highlighted. In
Table 4 Laboratory evaluation
Common tests
Complete blood count with differential cell counts
Erythrocyte sedimentation rate
Urinalysis
Prothrombin time (PT with INR), activated partial thromboplastin time
Serum electrolytes, liver and renal function tests
Blood glucose, hemoglobin A1C level
Lipid panel, lipoprotein (a) level, C-reactive protein level
Pregnancy test
Head CT, brain MRI
Cerebral arterial imaging: CT, MR, or digital subtraction angiography of the head and neck,
carotid artery Duplex ultrasound, transcranial Doppler ultrasound
Brain perfusion imaging, e.g., CT-perfusion or MR-perfusion (optional)
Transthoracic and/or transesophageal echocardiography
Holter monitoring
Selected tests for specific stroke etiologies
Serum and urine toxicology screen
Lower extremity ultrasound, pelvic CT or MR venography (in patients with PFO)
Advanced brain imaging: axial fat-suppressed T1-weighted MRI, high-resolution (3T) contrast-
enhanced T1-weighted MRI, PET scan, MR spectroscopy, transcranial Doppler ultrasound
studies for cerebrovascular “reserve”
CSF examination: opening and closing pressure, cell counts, protein and glucose level,
oligoclonal bands, cytology, immunoglobulin gene rearrangement analysis, and special tests for
viral, fungal, bacterial, and parasitic infections, mitochondrial disease, and rheumatologic
diseases
Rheumatologic panel blood tests: antinuclear antibody, antibody to double-stranded DNA,
rheumatoid factor, anticardiolipin antibodies, complement levels, cryoglobulin level, neutrophil
cytoplasm antibody (cANCA and pANCA), Scl-70 antibody, anti-centromere antibody, anti-Ro
(SSA) and anti-La (SSB) cytoplasmic antibodies, serum angiotensin-converting enzyme, anti-
proteinase 3
Infectious disease panel tests: varicella-zoster virus, herpes simplex virus, Epstein-Barr virus,
HIV, hepatitis B and C viruses, tuberculosis, syphilis, Lyme, and others
Hypercoagulable panel tests: protein C, protein S, and antithrombin levels, prothrombin gene
mutation, factor V Leiden mutation, and others
Hematologic panel tests: serum protein electrophoresis, homocysteine level, serum viscosity,
Coombs test, bone marrow aspiration biopsy, and others
Ophthalmologic evaluation: fluorescein retinal angiography, Schirmer test
Biopsy: brain/leptomeningeal, skin, temporal artery, sural nerve, muscle, etc.
Genetic tests: for conditions such as CADASIL, RVCL, MTHFR 677C-T pleomorphism, and
others
Abbreviations: CADASIL5 cerebral autosomal dominant arteriopathy with subcortical infarcts
and leukoencephalopathy; cANCA 5 cytoplasmic antineutrophil cytoplasmic antibodies; INR 5
international normalized ratio; MR 5 magnetic resonance; MTHFR 5 methylenetetrahydrofo-
late reductase; pANCA 5 perinuclear antineutrophil cytoplasmic antibodies; PFO 5 patent
foramen ovale; PT 5 prothrombin time; RVCL 5 retinal vasculopathy with cerebral
leukodystrophy.
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patients with cryptogenic stroke, device closure of a
PFO did not offer greater benefit than medical therapy
alone for preventing recurrent stroke.37–39 Evidence-
based guidelines do not recommend anticoagulation
over antiplatelet therapy for arterial dissection. In
patients with migraine with aura, smoking cessation
and aggressive treatment of vascular risk factors is
important; women should consider birth control with
methods other than estrogen-containing hormonal con-
traception. In patients with migraine who develop IS,
the above measures become even more relevant and
therapy with triptans and ergots is contraindicated.
Whether prophylactic migraine treatment affects future
stroke occurrence remains unclear. Hormonal contra-
ception is used by 15% to 35% of young women at the
time of the stroke.1,49 Clinical guidelines recommend
against using combined estrogen-progesterone contra-
ception in women with stroke.55 Progestin-only contra-
ceptives (pills or implants) can be initiated after stroke
but should be discontinued if the woman was taking it
when stroke occurred.55 Although pregnancy is not
contraindicated after stroke, young women with stroke
merit multidisciplinary discussions regarding the risks
of pregnancy. The teratogenicity of drugs such as statins
and angiotensin-converting enzyme inhibitors should
be noted.
PROGNOSIS Prognosis is an important issue in pre-
mature stroke because of the longer expected survival
compared with older people with stroke. In addition,
those affected by stroke in young adulthood often
have significant stress, and primary responsibility for
generating income for the family or providing child
care. Prognosis will be discussed in relationship to
mortality, stroke recurrence, and other vascular
events, poststroke epilepsy, functional outcome, post-
stroke depression and quality of life, return to work,
and other social consequences.
Mortality rates in a large study of first IS in
patients aged 15 to 49 years in Finland56 were 2.7%
(95% confidence interval [CI] 1.5%–3.9%) at
1 month, 4.7% (95% CI 3.1%–6.3%) at 1 year,
and 10.7% (95% CI 9.9%–11.5%) at 5 years, con-
sistent with prior smaller studies.49,57,58 Five-year
mortality was higher for those aged 45 and older
(14.7%) vs those younger than 45 (7%), and higher
for large-artery atherosclerosis (approximately 30%)
and cardioembolism (approximately 20%) vs other
determined or undetermined etiology or small-vessel
disease (approximately 5%–7%). The 5-year rate for
stroke recurrence and other vascular events, both
nonfatal and fatal, was 11.5% (95% CI 9.2%–
13.7%); independent predictors of higher rates were
type-1 diabetes, heart failure, large-artery atheroscle-
rosis, prior TIA, and increasing age.6 The 5-year rate
for poststroke epilepsy among patients with first IS
ages 15 to 49 in Norway58 was 10.5% overall, but
34% among patients with severe neurologic deficits
from index stroke.
Functional independence (no or slight disability
and able to look after own affairs without assistance;
modified Rankin Scale score #2) ranged from 78%58
to 85%59 to 94%.49 Diabetes and severe neurologic
deficits at admission were predictors of poor functional
outcome.58 Although most patients regained func-
tional independence, there was a high rate of post-
stroke depression ranging from 28%60 to 46%57;
fatigue, reported in 54%60; and impaired quality of
life, particularly in the SF-36 dimensions of physical
functioning, role limitations due to physical health,
and social functioning. Estimates of the percent return-
ing to work after stroke vary, but have been reported at
42%57 to 53%49 with 23% of those returning to work
requiring adjustments in their occupation. Other social
consequences of stroke have not been well studied in
large representative samples of young stroke patients.
Young adults with stroke frequently are parents of
young children. While quantitative estimates are lack-
ing, this role may be impaired in some stroke patients.
Limited data are available on changes in family struc-
ture; a French study reported a 7% divorce rate after a
mean follow-up of 3 years.49
SUGGESTIONS FOR RAISING AWARENESS
There has been a relative explosion in the number
of Web sites addressing young stroke (table 5). Many
discuss the need for greater awareness and provide
links to other sites as well as an opportunity for young
stroke victims and caregivers to tell their stories
and interact with others while also getting needed
Figure Diagnostic tests in young adults with ischemic stroke
White bars show the percentage of patients who underwent the test, and black bars show
the percentage of tests showing a “positive” result relative to stroke etiology (i.e., diagnostic
yield). See Methods for individual tests included under each panel. Hypercoag 5 hypercoa-
gulation panel; toxicology 5 serum/urine toxicology screening panel; vasc. labs 5 vasculitis
panel. From Ji R, Schwamm LH, Pervez MA, Singhal AB. Ischemic stroke and transient ische-
mic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis.
JAMA Neurol 2013;70:51–57. Reprinted with permission of the American Medical
Association.
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information. While coping with the shock of having a
stroke, younger survivors may be dealing with relation-
ships, careers, and raising children—issues that require
additional awareness and resources (appendix e-1 on
the Neurology® Web site at www.neurology.org).
Web sites allow people to donate money (online
charities) for young stroke, and offer research, mes-
sage boards, survivor stories, networking, and other
opportunities to connect. For example, The Stroke
Awareness and Support Association is a 501(c)3 non-
profit organization with a mission to raise awareness
on the prevalence of strokes at young ages occurring
each year in the United States, and to provide support
directly to younger stroke victims and their families.
Sickle Cell and Young Stroke Survivors is a registered
charity that was formerly set up as a support group for
parents/carers whose children have had a stroke. For
more than 2 years, the Stroke Awareness Foundation
in California has been working with the California
Department of Public Health to develop a plan of
stroke prevention that will serve everyone in Califor-
nia. They promote a Young Adult Stroke Survivor
Group (Stroke Awareness) that can be modeled in
other communities and countries. The Children’s
Hemiplegia and Stroke Association Web site provides
information and support to families of pediatric
stroke survivors. There is information on therapy,
dressing, school, and general support information
needed by parents who face the daily challenges of
raising a child with poststroke hemiplegia. The mis-
sion of YoungStroke, Inc. is to advocate the needs of
those who experienced their first stroke between ages
20 and 65. It provides information on research and
education initiatives.
Social media networking can provide additional
avenues for raising awareness and linking individuals
and families. Awareness can also be raised through
World Stroke Day Runs, Walks, and Family Events
that raise both money and awareness, support groups,
national stroke agencies (American Stroke Association,
National Stroke Association), local and national media,
and legislative and congressional initiatives (e.g., the
US Senate approved a resolution declaring May 6,
2006 as Childhood Stroke Awareness Day). Work-
place information about stroke risk, warning signs,
and what to do if one witnesses someone with a stroke
can help educate the public.
FUTURE DIRECTIONS While physicians, patients,
and caregivers grapple with the shifting landscape of
health care and its reform, it is crucial to include a voice
for young stroke victims and their caregivers in setting
national health priorities as the costs and burden of dis-
ability from young stroke continue to increase. As infor-
mation is increasingly spread rapidly via electronic media,
there is a great opportunity to connect people and resour-
ces. We need greater emphasis on teaching about young
stroke and its risk factors and warning signs in school,
at the workplace, in primary care physician’s offices,
and media. As an example of developing momentum,
the YoungStroke project (http://www.youngstroke.org/)
is a 5-year research initiative to document the experience
of young stroke survivors and to measure their
satisfaction with community services within the 28
coastal counties of South Carolina. The resulting
media report will serve as a resource for policy-makers
and health care providers. It will likely validate the
experience of an underserved patient population,
which could help increase resources and access to care
for young stroke survivors.
Given the increasing physical, emotional, and
financial burden young stroke causes, there will need
to be greater research into reducing this burden. The
formation of multicenter collaborative research groups
could help facilitate meaningful and practical aims. A
national young stroke registry could improve our
understanding of risk factors, identify research priori-
ties, and facilitate clinical trials of treatments and reha-
bilitative strategies of stroke in the young.
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